Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...
We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Qorvo ...
4d
Hosted on MSNBristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItBristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand ...
The 2025 forecast reflects a revenue hit of about 18% to 20% to the company's legacy portfolio from the near-term effects of generics on cancer drugs Revlimid, Pomalyst, Sprycel and Apraxane. The ...
Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly immunotherapy, but it is burdened by a lot of debt. Although the dividend yield ...
PRINCETON, N.J., January 31, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ...
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Breyanzi--Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the ...
He called on the CEOs of some of the largest pharmaceutical companies, including Merck, Bristol Myers Squibb and Johnson & Johnson to testify at the hearing. An in 2019, Sen Sanders, along with ...
Wall Street expects a year-over-year decline in earnings on higher revenues when Bristol Myers Squibb (BMY) reports results for the quarter ended December 2024. While this widely-known consensus ...
In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best blue chip stocks to buy under $100. Blue chip stocks have long been ...
In terms of shares owned, we count 4 of the above funds having increased existing BMY positions from 09/30/2024 to 12/31/2024, with 2 having decreased their positions and 4 new positions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results